If cancer stem cells are resistant to current therapies what's next?

Future Oncology

Volumn 5, Issue 6, 2009, Pages 747-750

  Marcato, Paola ^a   Dean, Cheryl A ^a   Giacomantonio, Carman A ^a   Lee, Patrick W K ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER;

BREAST CANCER; CANCER MORTALITY; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURVIVAL; CARCINOGENICITY; DNA REPAIR; EDITORIAL; EPIGENETICS; GAMMA IRRADIATION; GLIOBLASTOMA; HUMAN; METASTASIS POTENTIAL; MICROENVIRONMENT; NONHUMAN; PLEURA EFFUSION; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VASCULARIZATION;

DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; STEM CELLS;

EID: 70349220041     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.09.58     Document Type: Editorial

References (23)

1. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100(1), 57-70 (2000).
2. Dalerba P, Cho RW, Clarke MF: Cancer stem cells: models and concepts. Annu. Rev. Med. (2006).
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100(7), 3983-3988 (2003).
4. Charafe-Jauffret E, Ginestier C, Iovino F et al.: Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 69(4), 1302-1313 (2009).
5. Ginestier C, Hur MH, Charafe-Jauffret E et al.: ALDH1 is a market of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1(5), 555-567 (2007).
6. Wulf GG, Wang RY, Kuehnle I et al.: A leukemic stem cell with intrinsic drug efflux-capacity in acute myeloid leukemia. Blood 98(4), 1166-1173 (2001).
7. Todaro M, Alea MP, Di Stefano AB et al.: Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1(4), 389-402 (2007).
8. + cancer stem cells in glioblastoma. Mol. Cancer 5, 67 (2006).
9. + HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 27(12), 1749-1758 (2008).
10. Hermann PC, Huber SL, Herrler T et al.: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1(3), 313-323 (2007).
11. + breast cancer-initiating cells to radiation. J. Natl Cancer Inst. 98(24), 1777-1785 (2006).
12. Bao S, Wu Q, McLendon RE et al.: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444 (7120), 756-760 (2006).
13. Ponti D, Costa A, Zaffaroni N et al.: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/ progenitor cell properties. Cancer Res. 65(13), 5506-5511 (2005).
14. Marcato P, Dean CA, Giacomantonio CA, Lee PW: Oncolytic reovirus effectively targets breast cancer stem cells. Mol. Ther. 17(6), 972-979 (2009).
15. Gottesman MM, Fojo T, Bates SE: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2(1), 48-58 (2002).
16. Chapuy B, Koch R, Radunski U et al.: Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration. Leukemia 22(8), 1576-1586 (2008).
17. Magni M, Shammah S, Schiro R et al.: Induction of cyclophosphamide-resistance by aldehyde-dchydrogenase gene transfer. Blood 87(3), 1097-1103 (1996).
18. Nandi S, Ulasov IV, Tjler MA et al.: Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells. Cancer Res. 68(14), 5778-5784 (2008).
19. Mahller YY, Williams JP, Baird WH et al.: Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus. PLoS ONE 4(1), e4235 (2009).
20. Zhang X, Komaki R, Wang L, Fang B, Chang JY: Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. Clin. Cancer Res. 14(9), 2813-2823 (2008).
21. Ribacka C, Pesonen S, Hemminki A: Cancer, stem cells, and oncolytic viruses. Ann. Med. 40(7), 496-505 (2008).
22. Wakimoto H, Kesari S, Farrell CJ et al.: Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res. 69 (8), 3472-3481 (2009).
23. -/low cells. Mol Ther. 15(12), 2088-2093 (2007).